Isolating the first spark of life on Earth is a matter of biology, geology, and chemistry—but it's also an amazing math ...

Teachers can use these questions to draw students out and get worthwhile formative assessment responses to guide instruction.

Round of 64 play in the NCAA tournament begins on Thursday, but March Madness officially tips off on Tuesday night in Dayton. We're set for the First Four, which features a pair of play-in games on ...

A rock band is going on tour for the first time in more than 30 years, and they’re bringing an expanded lineup. Triumph will begin its 50th anniversary tour next month, including one concert in ...

WASHINGTON — The U.S. economy, hobbled by last fall's 43-day government shutdown, advanced at an unexpectedly sluggish 0.7% annual rate from October through December, the Commerce Department reported ...

This is read by an automated voice. Please report any issues or inconsistencies here. The U.S. economy, hobbled by last fall’s 43-day government shutdown, advanced at an unexpectedly sluggish 0.7% ...

The U.S. economy, hobbled by last fall’s 43-day government shutdown, advanced at a sluggish 0.7% annual rate from October through December, the Commerce Department reported Friday in a big downgrade ...

WASHINGTON — The US economy, hobbled by last fall’s 43-day government shutdown, advanced at an unexpectedly sluggish 0.7 percent annual rate from October through December, the Commerce Department ...

“This is our time — because why not?” declares Roksanda CEO Patricia Sancho, as we finish our interview on the top floor of the brand’s new store and concept space that opens today. Stretching over ...

The streaming home of X Games becomes the... streaming home of the X Games League. By Tony Maglio Roku just got a bit more Xtreme. The streaming-gateway and content ...

The academic effects of the pandemic weren’t just limited to school-age children. Kids who were babies and toddlers in the early years of COVID, currently in 1st and 2nd grades, are now struggling too ...

CHICAGO--(BUSINESS WIRE)--Emalex Biosciences today announced that the first patient was dosed in its Expanded Access Program for ecopipam, an investigational first-in-class D1 receptor antagonist in ...